Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2or its regulatory elements

Autor: Laver, Thomas W., Wakeling, Matthew N., Caswell, Richard C., Bunce, Benjamin, Yau, Daphne, Männistö, Jonna M. E., Houghton, Jayne A. L., Hopkins, Jasmin J., Weedon, Michael N., Saraff, Vrinda, Kershaw, Melanie, Honey, Engela M., Murphy, Nuala, Giri, Dinesh, Nath, Stuart, Tangari Saredo, Ana, Banerjee, Indraneel, Hussain, Khalid, Owens, Nick D. L., Flanagan, Sarah E.
Zdroj: European Journal of Human Genetics: EJHG; 20240101, Issue: Preprints p1-6, 6p
Abstrakt: Persistent congenital hyperinsulinism (HI) is a rare genetically heterogeneous condition characterised by dysregulated insulin secretion leading to life-threatening hypoglycaemia. For up to 50% of affected individuals screening of the known HI genes does not identify a disease-causing variant. Large deletions have previously been used to identify novel regulatory regions causing HI. Here, we used genome sequencing to search for novel large (>1 Mb) deletions in 180 probands with HI of unknown cause and replicated our findings in a large cohort of 883 genetically unsolved individuals with HI using off-target copy number variant calling from targeted gene panels. We identified overlapping heterozygous deletions in five individuals (range 3–8 Mb) spanning chromosome 20p11.2. The pancreatic beta-cell transcription factor gene, FOXA2, a known cause of HI was deleted in two of the five individuals. In the remaining three, we found a minimal deleted region of 2.4 Mb adjacent to FOXA2that encompasses multiple non-coding regulatory elements that are in conformational contact with FOXA2. Our data suggests that the deletions in these three children may cause disease through the dysregulation of FOXA2expression. These findings provide new insights into the regulation of FOXA2in the beta-cell and confirm an aetiological role for chromosome 20p11.2 deletions in syndromic HI.
Databáze: Supplemental Index
Externí odkaz: